FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. SupplyMay 26, 2022
FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula in Coming Months to Increase Supply Available to U.S. ConsumersMay 24, 2022
FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply ChainMay 19, 2022
New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement MarketplaceMay 19, 2022
Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 YearsMay 17, 2022
FDA Encourages Importation of Safe Infant Formula and Other Flexibilities to Further Increase AvailabilityMay 16, 2022
FDA Provides New Updates on Activities to Mitigate Infant Formula Supply Challenges, Abbott Nutrition Agrees to Take Corrective Actions at Facility to Produce Safe Infant FormulaMay 16, 2022
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSVMay 16, 2022
Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain IndividualsMay 5, 2022
